Commentary: Tailored therapy for Helicobacter pylori eradication: A systematic review and meta-analysis
Main Authors: | Toshihiko Kakiuchi, Masato Yoshiura |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1090776/full |
Similar Items
-
Comparing Clarithromycin- and Levofloxacin-Containing Triple Therapies for First Line Helicobacter pylori Eradication
in Mazandran Province, Iran
by: Sepehr Tirgar Fakheri, et al.
Published: (2019-09-01) -
APPROBATION OF OPTIMIZED REGIMENS OF ERADICATION THERAPY PEPTIC ULCER OF THE STOMACH AND DUODENUM, ASSOCIATED WITH HELICOBACTER PYLORI
by: Amiraslanova I. T.
Published: (2019-11-01) -
Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication
by: Fariborz Mansour-Ghanaei, et al.
Published: (2017-04-01) -
Tailored therapy for Helicobacter pylori eradication: A systematic review and meta-analysis
by: Qin Ma, et al.
Published: (2022-09-01) -
Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan
by: Mitsushige Sugimoto, et al.
Published: (2019-01-01)